MAPT and Parkinson disease: This is especially relevant given the association data of Labbe et al. (2015) implicating A152T in alpha-synucleinopathies, and the multitude of papers showing associations between the MAPT/tau haplotype and Parkinson’s disease risk (Desikan et al., 2015).